Related Experiment Video
Updated: Jan 9, 2026
04:48
Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair
Published on: March 1, 2024
2.3K
Decellularized Extracellular Matrix Produced by iPSC-Derived MSCs Promotes iPSC-MSC Proliferation and Differentiation
Tao Huang1,2, Michael Yang1,2, Claire Grant2,3
1Department of Biomedical Engineering, Graeme Clark Institute, The University of Melbourne, Parkville, Victoria, Australia.
Journal of Biomedical Materials Research. Part A
|December 3, 2025
Summary
Induced pluripotent stem cell-derived mesenchymal stromal cells (iPSC-MSCs) deposit more extracellular matrix (ECM) than other sources. This iPSC-MSC ECM enhances cell expansion and differentiation, crucial for regenerative therapies.
Area of Science:
- Regenerative Medicine
- Cell Biology
- Biomaterials Science
Background:
- Mesenchymal stromal cells (MSCs) are vital for regenerative therapies but face limitations in in vitro expansion due to premature senescence.
- Maintaining MSC therapeutic potential during large-scale cell production is a significant challenge.
- Novel culture environments are needed to support MSC properties during expansion.
Purpose of the Study:
- To investigate the potential of decellularized extracellular matrix (dECM) from various MSC sources for induced pluripotent stem cell-derived MSC (iPSC-MSC) expansion.
- To compare the dECM produced by iPSC-MSCs with dECMs from bone marrow MSCs (BMSCs) and a placenta-derived MSC cell line (DMSC23s).
- To evaluate the efficacy of these dECMs on conventional substrates like tissue culture plastic (TCP), collagen I, fibronectin, and Matrigel.
Main Methods:
- Generation and characterization of dECMs from iPSC-MSCs, BMSCs, and DMSC23s.
- Comparison of dECM deposition quantities across different MSC sources.
- Assessment of iPSC-MSC proliferation and lineage-specific differentiation on various dECM substrates.
- Analysis of secretome modulation using enzyme-linked immunosorbent assays (ELISAs).
Main Results:
- iPSC-MSCs deposited significantly more dECM (35-fold and 2-fold) compared to BMSCs and DMSC23s, respectively.
- The iPSC-MSC-derived dECM demonstrated superior promotion of MSC proliferation and differentiation.
- dECM culture conditions were shown to modulate the MSC secretome.
Conclusions:
- iPSC-MSCs and their deposited ECM represent a promising biomaterial for optimizing in vitro expansion of iPSC-MSCs.
- This approach offers potential advantages for upscaling cell production for regenerative medicine applications.
- Further research into iPSC-MSC-derived ECM could enhance the efficacy and reduce the cost of MSC-based therapies.
Related Concept Videos
01:22iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
01:19Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K